ZIPRASIDONE-ZP ziprasidone (as hydrochloride) 40 mg capsule blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

ziprasidone hydrochloride, Quantity: 43.44 mg (Equivalent: ziprasidone, Qty 40 mg)

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

Ziprasidone hydrochloride

Għamla farmaċewtika:

Capsule, hard

Kompożizzjoni:

Excipient Ingredients: croscarmellose sodium; colloidal anhydrous silica; Gelatin; titanium dioxide; magnesium stearate; pregelatinised maize starch; indigo carmine

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

60

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.

Sommarju tal-prodott:

Visual Identification: size 4 capsule: blue body, blue cap; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-03-05